… organization was founded in March 2014 to raise public awareness about the disease, support those with it and prepare health care professionals to address it. If Lyme disease is not caught early and treated properly, the disease enters a chronic …
Category: Chronic Fatigue Syndrome
Hemispherx BioPharma, Inc (HEB) Spikes On Extension Of Rintatolimod European EAP To Pancreatic Cancer
Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages. We only allow registered users to use ad blockers.
Hemispherx BioPharma CEO Talks About Ampligen, Alferon’s Potential
Hemispherx BioPharma, Inc is a nano-cap biopharmaceutical research and development company that focuses on the treatment of seriously debilitating disorders. Its flagship products include Alferon N Injection, Ampligen and Alferon LDO.